Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney Cancer Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney Cancer Treatment Drugsmarket, defines the market attractiveness level of Kidney Cancer Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney Cancer Treatment Drugs industry, describes the types of Kidney Cancer Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney Cancer Treatment Drugs market and the development prospects and opportunities of Kidney Cancer Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney Cancer Treatment Drugs market in Chapter 13.
By Player:
Argos Therapeutics
Merck
Amgen/Allergan
Incyte
Bristol-Myers Squibb
Bayer
Aveo Pharmaceuticals
Prometheus Labs
Novartis
Exelixis
Eisai
Roche
Pfizer
AstraZeneca
By Type:
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
By End-User:
Hospitals
Research Institutes
Diagnostic Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney Cancer Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney Cancer Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney Cancer Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney Cancer Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney Cancer Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.2 United States Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.4 China Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.6 India Kidney Cancer Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Kidney Cancer Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Kidney Cancer Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney Cancer Treatment Drugs Consumption Forecast (2022-2028)
9 Global Kidney Cancer Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Kidney Cancer Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney Cancer Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney Cancer Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney Cancer Treatment Drugs Market Competitive Analysis
-
14.1 Argos Therapeutics
-
14.1.1 Argos Therapeutics Company Details
-
14.1.2 Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Argos Therapeutics Kidney Cancer Treatment Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Kidney Cancer Treatment Drugs Product and Service
-
14.3 Amgen/Allergan
-
14.3.1 Amgen/Allergan Company Details
-
14.3.2 Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen/Allergan Kidney Cancer Treatment Drugs Product and Service
-
14.4 Incyte
-
14.4.1 Incyte Company Details
-
14.4.2 Incyte Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Incyte Kidney Cancer Treatment Drugs Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Kidney Cancer Treatment Drugs Product and Service
-
14.7 Aveo Pharmaceuticals
-
14.7.1 Aveo Pharmaceuticals Company Details
-
14.7.2 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product and Service
-
14.8 Prometheus Labs
-
14.8.1 Prometheus Labs Company Details
-
14.8.2 Prometheus Labs Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Prometheus Labs Kidney Cancer Treatment Drugs Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Kidney Cancer Treatment Drugs Product and Service
-
14.10 Exelixis
-
14.10.1 Exelixis Company Details
-
14.10.2 Exelixis Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Exelixis Kidney Cancer Treatment Drugs Product and Service
-
14.11 Eisai
-
14.11.1 Eisai Company Details
-
14.11.2 Eisai Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Eisai Kidney Cancer Treatment Drugs Product and Service
-
14.12 Roche
-
14.12.1 Roche Company Details
-
14.12.2 Roche Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Kidney Cancer Treatment Drugs Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Kidney Cancer Treatment Drugs Product and Service
-
14.14 AstraZeneca
-
14.14.1 AstraZeneca Company Details
-
14.14.2 AstraZeneca Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 AstraZeneca Kidney Cancer Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney Cancer Treatment Drugs
-
Figure Kidney Cancer Treatment Drugs Picture
-
Table Global Kidney Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney Cancer Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney Cancer Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiogenesis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Angiogenesis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokine Immunotherapy (IL-2) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics Kidney Cancer Treatment Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Kidney Cancer Treatment Drugs Product and Service
-
Table Amgen/Allergan (Foundation Year, Company Profile and etc.)
-
Table Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen/Allergan Kidney Cancer Treatment Drugs Product and Service
-
Table Incyte (Foundation Year, Company Profile and etc.)
-
Table Incyte Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Kidney Cancer Treatment Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Kidney Cancer Treatment Drugs Product and Service
-
Table Aveo Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product and Service
-
Table Prometheus Labs (Foundation Year, Company Profile and etc.)
-
Table Prometheus Labs Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Labs Kidney Cancer Treatment Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Kidney Cancer Treatment Drugs Product and Service
-
Table Exelixis (Foundation Year, Company Profile and etc.)
-
Table Exelixis Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Kidney Cancer Treatment Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Kidney Cancer Treatment Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kidney Cancer Treatment Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Cancer Treatment Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Kidney Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Kidney Cancer Treatment Drugs Product and Service
-
